
Identifeye is creating prediction models that combine multiple retinal imaging modalities with expert annotations to create comprehensive and non-invasive health assessments. Identifeye Health is a part of the 4Catalyzer accelerator, which is dedicated to improving patient care globally. It has offices in Guilford, Connecticut, New York City, and Palo Alto, California.

Identifeye is creating prediction models that combine multiple retinal imaging modalities with expert annotations to create comprehensive and non-invasive health assessments. Identifeye Health is a part of the 4Catalyzer accelerator, which is dedicated to improving patient care globally. It has offices in Guilford, Connecticut, New York City, and Palo Alto, California.
What they do: Portable retinal-imaging hardware and AI-driven retinal diagnostic/monitoring platform
HQ / founded: Guilford, Connecticut; founded circa 2018
Latest disclosed round: Series B (announced Apr 20, 2021)
Known investors: Foresite Capital, Glenview Capital Management, Opaleye Management, Affinity Asset Advisors
Medical imaging and diagnostics focused on retinal-based disease detection and monitoring.
2018
Medtech / Healthcare
80000000.00
Round reported with four institutional investors including Foresite Capital, Glenview Capital Management, Opaleye Management, and Affinity Asset Advisors; reported amount $80,000,000 on Dealroom; Crunchbase lists the Series B on Apr 20, 2021.
“Foresite Capital, Glenview Capital Management, Opaleye Management, Affinity Asset Advisors participated in the Series B”